Special Promotion- Free Shipping - Limited Time Offer!
PectaSol Modified Citrus Pectin is a patent protected, complex polysaccharide derived form citrus fruits. PectaSol is manufactured using a proprietary process that results in a shorter molecular chain for better absorption through the digestive tract into the bloodstream.
PectaSol-C Modified Citrus Pectin is a natural product derived from pith of citrus fruit, and modified to meet specific molecular chain and weight characteristics. This non- allergnic product is clinically recognized for its ability to support healthy cellular proliferation.
- Supports cellular health
- Promote prostate and breast health
- Supports heathy immne function.
Pectasol has been shown to support healthy prostate function and strengthen the immune system. PectaSol is the only form of Modified Citrus Pectin that has been validated by human clinical trials.
Ingredients: 6 caps contain
Sodium 90 mg,Potassium 600 mg,Pectasol Modified Citrus Pectin 4.8 g
Other Ingredients: Vegetable capsule(natural vegetable cellulose, water), stearic acid, magnesium stearate, silicon dioxide, microcrystalline cellulose.
As a dietary supplement, Take six capsules daily, or as directed by your health care professional. store in a cool, dry place with cap ightly closed.
PectaSol Modified Citrus Pectin is a complex polysaccharide (long-chain carbohydrate) obtained from the peel and pulp of citrus fruits and valued for its galactosyl component. It is modified to produce a shorter chain, low esterification pectin molecule which is more easily abosrbed into the bloodstream through the digestive tract. The unique galactosyl component of PectaSol® MCP has an affinity for the binding galectin-3 sites, limiting the binding of certain cells to each other or blood vessels.Citrus pectin is also recognized for its ability to promote cardiovascular health.
PectaSol® MCP has been clinically demonstrated to slow PSA doubling time in prostate cells.* It is known to promote normal cell growth by interfeing with the binding properties of galectin proteins by preventing them from adhering to each other and the inner wall of blood vessels.
Pectasol Modified Citrus Pectin FAQ:
What is pectin and how does PectaSol® Modified Citrus Pectin differ from ordinary pectin?
Ordinary pectin is a complex carbohydrate molecule found in almost all plants. It is recognized for its ability to gel (as in the making of jams), but is not absorbed into the bloodstream because of its long molecular chain. For modified citrus pectin, a special manufacturing process creates a shorter molecular chain. According to the scientific research, that modification enhances absorption and utilization of the crucial polysaccharide compounds. Pecta-Sol® Modified Citrus Pectin is a trademarked version of modified citrus pectin which conforms to the published specifications used in scientific research.
How long can PectaSol® Modified Citrus Pectin be safely used?
The scientific research on modified citrus pectin lists no adverse affects or toxicity. PectaSol® Modified Citrus Pectin matches the specifications used in scientific research studies. Consumption can continue for as long as desired.
Do people experience adverse reactions to PectaSol® Modified Citrus Pectin?
There are thousands of satisfied users of PectaSol® Modified Citrus Pectin. Since the introduction of this product line, we have received very few reports of mild, self-limiting adverse effects such as loose stools. No pattern of adverse reaction has been recorded in the scientific literature or by consumers.
Is PectaSol® Modified Citrus Pectin safe for diabetics to use?
When introducing any new food product, diabetics should be cautious. Therefore, we recommend closely monitoring blood sugar levels under your doctor’s supervision while you begin to use this product, as you would when introducing any item in your diet.
How does PectaSol® Modified Citrus Pectin compare to other products which describe themselves as "Modified Citrus Pectin" or "Fractionated Citrus Pectin"?
PectaSol® Modified Citrus Pectin is manufactured strictly according to the parameters of scientific research on modified citrus pectin. According to the specifications outlined in the Pienta research, the pectin should have a "methoxylation rate" of no more than 10%. Increased methoxylation potentially reduces the pectin binding sites which bind with the receptor sites of aberrant cells. Products that are sold as "modified citrus pectin" which exceed the 10% methoxylation rate given by the Pienta research team do not conform to the study specifications nor do they match the products used in the clinical research.
Treated pectinic acid, sometimes referred to as "Fractionated Citrus Pectin", is manufactured under Patent #5,498,702 and was initially developed as an aspartame replacement. Its pH and methoxylation rates do not match the specifications established by the Pienta research team in their research on the role of modified citrus pectin and metastasis.